ProfileGDS4718 / 200011_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 98% 98% 95% 98% 98% 95% 94% 98% 98% 98% 98% 98% 97% 95% 97% 96% 98% 96% 97% 95% 97% 98% 98% 98% 97% 96% 98% 95% 98% 96% 97% 95% 98% 98% 95% 95% 95% 98% 98% 95% 98% 96% 97% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.430398
GSM549102patient 115, normal, homogenized [OPG study]11.573898
GSM549104patient 119, normal, homogenized [OPG study]10.339395
GSM549108patient 138, normal, homogenized [OPG study]11.317298
GSM549119patient 077, normal, homogenized [OPG study]11.418498
GSM549133patient 032, cancer, homogenized [OPG study]10.372995
GSM549139patient 042, cancer, homogenized [OPG study]10.012894
GSM549099patient 107, normal, homogenized [OPG study]11.463198
GSM549109patient 139, normal, homogenized [OPG study]11.467198
GSM549110patient 046, normal, homogenized [OPG study]11.500698
GSM549114patient 063, normal, homogenized [OPG study]11.510698
GSM549122patient 082, normal, homogenized [OPG study]11.388298
GSM549134patient 033, cancer, homogenized [OPG study]11.079997
GSM549136patient 036, cancer, homogenized [OPG study]10.289995
GSM549140patient 044, cancer, homogenized [OPG study]10.850897
GSM549111patient 047, normal, homogenized [OPG study]10.815296
GSM549113patient 057, normal, homogenized [OPG study]11.404698
GSM549132patient 031, cancer, homogenized [OPG study]10.297296
GSM549137patient 038, cancer, homogenized [OPG study]10.804897
GSM549142patient 047, cancer, homogenized [OPG study]9.7664595
GSM549100patient 110, normal, homogenized [OPG study]11.179697
GSM549107patient 135, normal, homogenized [OPG study]11.325698
GSM549115patient 068, normal, homogenized [OPG study]11.50298
GSM549116patient 072, normal, homogenized [OPG study]11.368898
GSM549120patient 078, normal, homogenized [OPG study]11.080597
GSM549131patient 030, cancer, homogenized [OPG study]10.480396
GSM549118patient 074, normal, homogenized [OPG study]11.385798
GSM549129patient 027, cancer, homogenized [OPG study]10.048295
GSM549123patient 088, normal, homogenized [OPG study]11.593998
GSM549124patient 006, cancer, homogenized [OPG study]10.221796
GSM549126patient 015, cancer, homogenized [OPG study]10.83397
GSM549128patient 025, cancer, homogenized [OPG study]10.235595
GSM549103patient 117, normal, homogenized [OPG study]11.359998
GSM549117patient 073, normal, homogenized [OPG study]11.669498
GSM549138patient 041, cancer, homogenized [OPG study]10.115895
GSM549141patient 045, cancer, homogenized [OPG study]10.175295
GSM549130patient 028, cancer, homogenized [OPG study]10.187195
GSM549101patient 111, normal, homogenized [OPG study]11.127898
GSM549105patient 128, normal, homogenized [OPG study]11.425798
GSM549106patient 134, normal, homogenized [OPG study]10.298395
GSM549112patient 048, normal, homogenized [OPG study]11.833398
GSM549125patient 011, cancer, homogenized [OPG study]10.514296
GSM549127patient 024, cancer, homogenized [OPG study]10.605597
GSM549135patient 035, cancer, homogenized [OPG study]10.462496